BULLETIN ON COVID-19
|
#Unite2FightCorona #IndiaFightsCorona
Press Information Bureau
Ministry of Information & Broadcasting
Government of India
*****
India’s Cumulative COVID-19 Vaccination Coverage exceeds 188.19 Cr
Over 2.75 Cr 1st dose vaccines administered for age group 12-14 years
India's Active caseload currently stands at 16,279
2,927 new cases reported in the last 24 hours
Recovery Rate currently stands at 98.75%
Weekly Positivity Rate is presently at 0.59%
India’s COVID-19 vaccination coverage has exceeded 188.19 Cr (1,88,19,40,971) as per provisional reports till 7 am today. This has been achieved through 2,31,48,146 sessions.
COVID-19 vaccination for the age group 12-14 years was started on 16 March, 2022. So far, more than 2.75 Cr (2,75,34,619) adolescents have been administered with the first dose of COVID-19 vaccine. Similarly, the COVID-19 precaution dose administration for age group 18-59 years also started from 10th April, 2022 onwards. 5,17,547 precaution doses have been administered in age group 18-59 years so far.
The break-up of the cumulative figure as per the provisional report till 7 am today include:
Cumulative Vaccine Dose Coverage | ||
HCWs | 1st Dose | 10404907 |
2nd Dose | 10013922 | |
Precaution Dose | 4736567 | |
FLWs | 1st Dose | 18415248 |
2nd Dose | 17535036 | |
Precaution Dose | 7447184 | |
Age Group 12-14 years | 1st Dose | 27534619 |
2nd Dose | 4387961 | |
Age Group 15-18 years | 1st Dose | 58259733 |
2nd Dose | 41747337 | |
Age Group 18-44 years | 1st Dose | 555580353 |
2nd Dose | 476585631 | |
Precaution Dose | 113334 | |
Age Group 45-59 years | 1st Dose | 202896880 |
2nd Dose | 187607925 | |
Precaution Dose | 404213 | |
Over 60 years | 1st Dose | 126848678 |
2nd Dose | 116875848 | |
Precaution Dose | 14545595 | |
Precaution Dose | 2,72,46,893 | |
Total | 1,88,19,40,971 | |
India’s Active Caseload currently stands at 16,279. Active cases now constitute 0.04% of the country's total Positive Cases.
Consequently, India’s recovery rate stands at 98.75%. 2,252 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,25,25,563.
2,927 new cases were reported in the last 24 hours.
The last 24 hours saw a total of 5,05,065 COVID-19 tests being conducted. India has so far conducted over 83.59 Cr (83,59,74,079) cumulative tests.
Weekly Positivity Rate in the country currently stands at 0.59% and the Daily Positivity rate is also reported to be 0.58%.
https://www.pib.gov.in/PressReleasePage.aspx?PRID=1820335
Update on COVID-19 Vaccine Availability in States/UTs
More than 192.88 Crore vaccine doses provided to States/UTs
More than 19.70 Crore balance and unutilized vaccine doses still available with States/UTs
The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The nationwide COVID 19 vaccination started on 16th January 2021. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.
|
(As on 27th April 2022) |
SUPPLIED |
1,92,88,44,535 |
BALANCE AVAILABLE
|
19,70,98,585 |
More than 192.88 crore (1,92,88,44,535) vaccine doses have been provided to States/UTs so far through Govt. of India (free of cost channel) and through direct state procurement category.
More than 19.70 Cr (19,70,98,585) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.
https://www.pib.gov.in/PressReleasePage.aspx?PRID=1820327
TWEET LINKS
Post a Comment
Please do not enter any spam links in the comments box.